Dr. Durrant is an entrepreneur, board member, C-level executive, former big pharma executive, and an MD by original training. He is Chairman and CEO of Humanigen, a Nasdaq-listed public company developing biologics for a range of serious and life-threatening conditions. His specialty is both startups and turnarounds, including brands and business units as well as...
Dr. Pombo-Villar is currently the CTO of TargImmune Therapeutics AG in Switzerland. He held the post of CEO position from its seed stage in 2017 until August 2021. Under his leadership, the company developed the innovative targeted immunooncology platform and its lead project into IND-enabling studies, established the operations in Basel, and raised over CHF...
Dr. Mitchell is Co-Founder, President, and Chairman of iOncologi, Inc., a biotechnology ‘spinout’ company from the University of Florida (UF) specializing in immuno-oncology. Dr. Mitchell is the Phyllis Kottler Friedman Professor in the Lillian S. Wells Department of Neurosurgery at UF. He serves as Director of the UF Clinical Translational Science Institute (CTSI) and Co-Director...
Fumihiko “Fumi” Urano, MD, PhD, FACMG, is a Physician and Medical Researcher specializing in Wolfram syndrome, characterized by juvenile-onset diabetes, vision loss, and brain system disruption. Dr. Urano is a Professor of Medicine and Pathology & Immunology, an attending physician, and currently holds Samuel E. Schechter Endowed Professorship in Medicine at Washington University School of...